Bluefin Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,000
Closed -$160K 690
2022
Q2
$160K Buy
+40,000
New +$2.78M 0.02% 314
2022
Q1
Sell
-71,000
Closed -$2K 976
2021
Q4
$2K Hold
71,000
﹤0.01% 870
2021
Q3
$13K Hold
71,000
﹤0.01% 644
2021
Q2
$22K Hold
71,000
﹤0.01% 554
2021
Q1
$67K Sell
71,000
-110,000
-61% -$5.56M ﹤0.01% 589
2020
Q4
$141K Buy
+181,000
New +$5.84M 0.01% 477
2020
Q3
Sell
-120,000
Closed -$3.07M 209
2020
Q2
$207K Hold
120,000
0.02% 232
2020
Q1
$246K Buy
+120,000
New +$3.44M 0.03% 235
2017
Q4
Sell
-125,100
Closed -$233K 593
2017
Q3
$233K Sell
125,100
-74,900
-37% -$1.27M 0.03% 305
2017
Q2
$175K Buy
+200,000
New +$3.49M 0.02% 344

Other funds holding THC

Bluefin Capital Management's THC Position: Q3 2022 in Review

Bluefin Capital Management sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 16,338 shares — an estimated $924K sold.

Bluefin Capital Management first reported a position in THC in Q2 2017 and held it in 10 quarters. The position peaked at $32.2M in Q4 2021. 362 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Bluefin Capital Management reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 16,338 Tenet Healthcare shares in Q3 2022, an estimated $924K.
  • Bluefin Capital Management first reported a position in Tenet Healthcare in Q2 2017 and held it in 10 quarters.
  • Bluefin Capital Management's Tenet Healthcare position peaked at $32.2M in Q4 2021.
  • 362 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Bluefin Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.